SEC Form 4 · accession 0001179110-15-012305
Celldex Therapeutics, Inc. · CLDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Ellberger
Director
Period of report
Aug 18, 2015
Accepted (ET)
Aug 19, 2015 · 7:33 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000744218
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per share | Aug 18, 2015 | P | 300 | $15.93 | A | 38,800 | D | |
| Common Stock, par value $0.001 per share | Aug 18, 2015 | P | 2,200 | $15.94 | A | 41,000 | D | |
| Common Stock, par value $0.001 per share | Aug 18, 2015 | P | 2,500 | $15.96 | A | 43,500 | D |
Table II — derivative securities
No Table II lines on this filing.